A Rapid and Sensitive Method for Determination of Escital-Opram in Human Plasma and Its Application in Pharmacokinetic Study by Liquid Chromatography-Tandem Mass Spectrometry

Qian Yang,Wenying Liu,Feng Zheng,Juntian Xu,Jie Rao,Sun Di,Gao Shu

2006-01-01

Abstract:AIM: To determine the concentration of escitalopram in human plasma by HPLC-MS/MS and investigate the pharmacokinetics of escitalopram. METHODS: The method involved protein precipitation with methanol. The chromatographic separation was achieved within 6.0 min by using methanol-water with 15 mmol·L -1 ammonium acetate-formic acid (7228 0.1 , v/v/v) as mobile phase and a Lichrospher CN 150 mm× 4.6 mm analytical column. The analytes were detected using an electrospray ionization tandem mass spectrometry in SRM mode. Detection of the ions was performed by monitoring the transitions of m/z 325.0 to 234.0 for escitalopram and m/z 409.1 to 238.1 for amlodipine (internal standard), respectively. RESULTS: The standard curve was linear (r= 0.999 ) over the concentration range of 0.20 - 50.00 ng·ml -1 . Accuracy and precision were below the acceptance limits of 15%. The recoveries of escitalopram ranged from 96.0 % to 103.6 %. The lower limit of quantification for escitalopram was 0.20 ng·ml -1 using 200 μl plasma sample. The pharmacokinetic parameters of escitalopram after a single oral dosing of escitalopram oxalate tablet (10 mg) to ten healthy male volunteers were achieved. The C_ max , T_ max , AUC_ 0-t , AUC_ 0-∞ , t_ 1/2 and K_e of escitalopram were 9.21 ± 2.10 ng·ml -1 , 3.75 ± 1.04 h, 514.6 ± 152.3 ng·h·ml -1 , 540.5 ± 162.3 ng·h·ml -1 , 34.06 ± 7.71 h and 0.021 ± 0.004 h -1 , respectively. CONCLUSION: The determination of concentration of escitalopram in human plasma by HPLC-MS/MS method was rapid, sensitive and reliable. It can be used for clinical pharmacokinetic study of escitalopram.